Buprenorphine 101

Buprenorphine 101

Description

This training is designed to provide foundational knowledge and skills in initiating buprenorphine treatment for opioid use disorder in the outpatient setting in the context of the widespread presence of illicitly manufactured fentanyl. We explore how the potency and prevalence of fentanyl complicates the initiation phase of buprenorphine treatment, leading to potential clinical challenges such as precipitated withdrawal. We suggest participating in the next training in the series, Buprenorphine 201, upon completing Buprenorphine 101.

Objectives

At the end of this training, participants will have the knowledge necessary to:

• Identify the impact of illicitly manufactured fentanyl on buprenorphine initiation and its unique challenges in treatment.
• Describe at least 2 strategies for initiating buprenorphine in individuals with opioid use disorder.
• Develop an individualized, comprehensive care plan for initiating buprenorphine in an outpatient setting.

Learn More and Register

For trainings that indicate Continuing Education Units (CEUs) are available, contact the organizer and/or the Vermont Office of Professional Regulation to verify that the credits will count toward the continuing education requirements of your licensure or certification.